These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16823919)

  • 1. A novel adjuvant complex, tyrosine-MPL, for prophylactic and therapeutic vaccines.
    Wheeler A
    Vaccine; 2006 Apr; 24 Suppl 2():S2-40-1. PubMed ID: 16823919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergy vaccines--new approaches to an old concept.
    Wheeler AW; Woroniecki SR
    Expert Opin Biol Ther; 2004 Sep; 4(9):1473-81. PubMed ID: 15335314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines.
    Wheeler AW; Marshall JS; Ulrich JT
    Int Arch Allergy Immunol; 2001 Oct; 126(2):135-9. PubMed ID: 11729351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergoid-specific T-cell reaction as a measure of the immunological response to specific immunotherapy (SIT) with a Th1-adjuvanted allergy vaccine.
    von Baehr V; Hermes A; von Baehr R; Scherf HP; Volk HD; Fischer von Weikersthal-Drachenberg KJ; Woroniecki S
    J Investig Allergol Clin Immunol; 2005; 15(4):234-41. PubMed ID: 16433203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardisation of glutaraldehyde-modified tyrosine-adsorbed tree pollen vaccines containing the Th1-inducing adjuvant, monophosphoryl lipid A (MPL).
    Hopkins M; Lees BG; Richardson DG; Woroniecki SR; Wheeler AW
    Allergol Immunopathol (Madr); 2001; 29(6):245-54. PubMed ID: 11834183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections.
    Drachenberg KJ; Wheeler AW; Stuebner P; Horak F
    Allergy; 2001 Jun; 56(6):498-505. PubMed ID: 11421893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responses.
    Puggioni F; Durham SR; Francis JN
    Allergy; 2005 May; 60(5):678-84. PubMed ID: 15813815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal, liposome-adjuvanted cockroach allergy vaccines made of refined major allergen and whole-body extract of Periplaneta americana.
    Meechan P; Tungtrongchitr A; Chaisri U; Maklon K; Indrawattana N; Chaicumpa W; Sookrung N
    Int Arch Allergy Immunol; 2013; 161(4):351-62. PubMed ID: 23689057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvants in Allergen-Specific Immunotherapy: Modulating and Enhancing the Immune Response.
    Zubeldia JM; Ferrer M; Dávila I; Justicia JL
    J Investig Allergol Clin Immunol; 2019; 29(2):103-111. PubMed ID: 30418155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of adjuvants in allergen-immunotherapy.
    Klimek L; Schmidt-Weber CB; Kramer MF; Skinner MA; Heath MD
    Expert Rev Clin Immunol; 2017 Jun; 13(6):599-610. PubMed ID: 28162007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DNA vaccines against allergy].
    Sato Y; Kasukawa R
    Nihon Rinsho; 2000 Jun; 58(6):1307-14. PubMed ID: 10879058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adsorption of allergoids and 3-O-desacyl-4'-monophosphoryl lipid A (MPL®) to microcrystalline tyrosine (MCT) in formulations for use in allergy immunotherapy.
    Bell AJ; Heath MD; Hewings SJ; Skinner MA
    J Inorg Biochem; 2015 Nov; 152():147-53. PubMed ID: 26337118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pollinex Quattro: an innovative four injections immunotherapy in allergic rhinitis.
    Rosewich M; Lee D; Zielen S
    Hum Vaccin Immunother; 2013 Jul; 9(7):1523-31. PubMed ID: 23584250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Fusion Protein Consisting of the Vaccine Adjuvant Monophosphoryl Lipid A and the Allergen Ovalbumin Boosts Allergen-Specific Th1, Th2, and Th17 Responses In Vitro.
    Schülke S; Vogel L; Junker AC; Hanschmann KM; Flaczyk A; Vieths S; Scheurer S
    J Immunol Res; 2016; 2016():4156456. PubMed ID: 27340679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mannoside-glycocluster adjuvant: Compared in vitro to CpG ODN and MPL and tested in vivo in mouse asthma model.
    Mäkinen K; Mukherjee C; Leino M; Panchadhayee R; Lehto M; Wolff H; Alenius H; Leino R; Savolainen J
    Allergol Immunopathol (Madr); 2016; 44(1):9-17. PubMed ID: 26395525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic changes associated with allergen immunotherapy.
    Durham SR; Till SJ
    J Allergy Clin Immunol; 1998 Aug; 102(2):157-64. PubMed ID: 9723654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1.
    Sirvent S; Soria I; Cirauqui C; Cases B; Manzano AI; Diez-Rivero CM; Reche PA; López-Relaño J; Martínez-Naves E; Cañada FJ; Jiménez-Barbero J; Subiza J; Casanovas M; Fernández-Caldas E; Subiza JL; Palomares O
    J Allergy Clin Immunol; 2016 Aug; 138(2):558-567.e11. PubMed ID: 27177779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-short-course seasonal allergy vaccine (Pollinex Quattro).
    McCormack PL; Wagstaff AJ
    Drugs; 2006; 66(7):931-8. PubMed ID: 16740007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous vaccination with coated microneedles prevents development of airway allergy.
    Shakya AK; Lee CH; Gill HS
    J Control Release; 2017 Nov; 265():75-82. PubMed ID: 28821461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.